Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotypic variability in human prion diseases.

J W Ironside1, D L Ritchie, M W Head

  • 1National Creutzfeldt-Jakob Disease Surveillance Unit, Division of Pathology, University of Edinburgh, UK. james.ironside@ed.ac.uk

Neuropathology and Applied Neurobiology
|November 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential overexpression of SERPINA3 in human prion diseases.

Scientific reports·2017
Same author

Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.

Journal of neurology, neurosurgery, and psychiatry·2014
Same author

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Neuropathology and applied neurobiology·2012
Same author

Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain.

Neuropathology and applied neurobiology·2012
Same author

RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue.

Neuropathology and applied neurobiology·2011
Same author

A new index of agonal state for neurological disease.

Neuropathology and applied neurobiology·2011
Same journal

Diagnostic Alteration Is Not Therapeutic Dependency: Lessons From Failed RET Inhibition in a PLAG-Altered CNS Embryonal Tumour.

Neuropathology and applied neurobiology·2026
Same journal

Respone to Škudar.

Neuropathology and applied neurobiology·2026
Same journal

Unravelling the Significance of Cystatin C and Bunina Bodies in Amyotrophic Lateral Sclerosis Pathogenesis.

Neuropathology and applied neurobiology·2026
Same journal

Neuropathological and Molecular Features Associated With a Heterozygous DNAJC7 Mutation in Amyotrophic Lateral Sclerosis.

Neuropathology and applied neurobiology·2026
Same journal

Central Nervous System Embryonal Tumour With PLAGL Amplification Lacking Typical Embryonal Morphology: Diagnostic Pitfall in a Paediatric Case.

Neuropathology and applied neurobiology·2026
Same journal

Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies.

Neuropathology and applied neurobiology·2026
See all related articles

Human prion diseases exhibit diverse phenotypes influenced by prion protein gene variations. Understanding these variations, like codon 129 polymorphism and prion protein isoforms, is key to classifying disease subtypes and their clinical features.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Human prion diseases are rare neurodegenerative disorders with varied presentations.
  • Phenotypic diversity in these diseases is greater than in other neurodegenerative conditions.
  • The prion protein (PrP) and its gene are central to disease pathogenesis.

Purpose of the Study:

  • To explore factors influencing human prion disease phenotypes.
  • To investigate the role of prion protein gene polymorphism and isoforms in disease diversity.
  • To understand the concept of molecular strain typing in prion diseases.

Main Methods:

  • Analysis of prion protein gene polymorphism, specifically at codon 129.
  • Study of abnormal prion protein isoforms in brain and other tissues.

Related Experiment Videos

  • Molecular strain typing to differentiate prion agent strains based on protein isoforms.

    • Main Results:

    • Codon 129 polymorphism significantly impacts disease phenotype across sporadic, familial, and acquired prion diseases.
    • At least six combinations of codon 129 genotype and prion protein isotype exist in sporadic Creutzfeldt-Jakob disease, correlating with clinical subgroups.
    • Complex interactions between genotypes and multiple prion protein isotypes complicate phenotype-genotype relationships.

    Conclusions:

    • Prion protein gene variations and isoforms are critical determinants of human prion disease phenotypes.
    • Molecular strain typing offers a framework for understanding disease diversity.
    • Further research is needed to elucidate mechanisms underlying neuropathological targeting and clinical variability.